Regan William J. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 19, 2013
Insider Transaction Report
Form 4
Regan William J.
SVP of lobal Regulatory Strate
Transactions
- Award
Stock Option (Right to Buy)
2013-02-15+100,000→ 100,000 totalExercise: $3.08Exp: 2023-02-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.